PARP1 and cancer: One of the views is that inhibitors of parthanatos, such as PARP1 inhibitors, could facilitate cancer cell death via inhibiting the DNA repair needed for cell survival, while other ideas are that inducers of parthanatos could directly promote cancer cell death (74) (Table 3).